An interventional study of Childhood vaccination decision support tool in Vaccine Refusal, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-18.
Sponsored by Duke University · Not applicable, Interventional, and Prevention
The purpose of this study is to develop and evaluate a tool designed to help parents make decisions about childhood vaccines.
42 studies on the registry are indexed under Vaccination Hesitancy; 7 are open to participants now.
This study's enrollment of 17 is below the median of 390 across 39 interventional studies indexed under Vaccination Hesitancy.
Browse Vaccination Hesitancy studies →Duke University is the lead sponsor of 2,058 studies on the registry; 274 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 165 (81%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive childhood vaccination decision support tool
Other: Childhood vaccination decision support tool
Participants receive childhood vaccination decision support tool
Change in Knowledge Related to Childhood Vaccinations as Measured by Study Specific Questionnaire
Study specific questionnaire comprised of 10 True or False questions. Knowledge was measured on a score of 0-10, where a higher score indicates a greater level of knowledge. Outcome reports on the difference in the knowledge score measure pre- and post- exposure to intervention.
Time frame: pre-survey (baseline) and post-survey (at completion of intervention, approximately 4-6 weeks after baseline)
Change in Acceptability of Childhood Vaccinations
Time frame: pre-survey (baseline) and post-survey (at completion of intervention, approximately 4-6 weeks after baseline)
| Milestone | Childhood Vaccination Decision Support Tool |
|---|---|
| Started | 17 |
| Completed | 11 |
| Not completed | 6 |
| Withdrew: Lost to follow-up | 6 |
Study specific questionnaire comprised of 10 True or False questions. Knowledge was measured on a score of 0-10, where a higher score indicates a greater level of knowledge. Outcome reports on the difference in the knowledge score measure pre- and post- exposure to intervention.
| score on a scale | Childhood Vaccination Decision Support Tool |
|---|---|
| Change in Knowledge Related to Childhood Vaccinations as Measured by Study Specific Questionnaire | 1.27 ± 1.68 |
No measurements were reported for this outcome.
Collected over Approximately 4-6 weeks. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Childhood Vaccination Decision Support Tool | 0/17 (0%) | 0/17 (0%) | 0/17 (0%) |
| Age, Continuous(years) | Childhood Vaccination Decision Support Tool |
|---|---|
| Mean | 34.06 ± 7.33 |
| Sex: Female, Male(Participants) | Childhood Vaccination Decision Support Tool |
|---|---|
| Female | 17 |
| Male | 0 |
| Ethnicity (NIH/OMB)(Participants) | Childhood Vaccination Decision Support Tool |
|---|---|
| Hispanic or Latino | 0 |
| Not Hispanic or Latino | 17 |
| Unknown or Not Reported | 0 |
| Race (NIH/OMB)(Participants) | Childhood Vaccination Decision Support Tool |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 2 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 8 |
| White | 6 |
| More than one race | 1 |
| Unknown or Not Reported | 0 |
| Region of Enrollment(Participants) | Childhood Vaccination Decision Support Tool |
|---|---|
| United States | 17 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.